Vendor Transparency Index
Independent editorial scoring of 10 peptide and telehealth vendors on five public criteria. Methodology disclosed. Updated quarterly.
Methodology
Each vendor is scored on five criteria totaling 100 points. Sources are public: FDA Warning Letters database, Trustpilot, BBB, Reddit r/Peptides monthly vendor threads, ICANN/WHOIS for ownership disclosure, and our own direct review of each vendor's public site, terms, and marketing language.
- FDA posture (25 pts) — no warning letters, recalls, or enforcement actions in the last 24 months.
- COA publication (25 pts) — publishes batch-level Certificates of Analysis from independent labs, accessible per-product.
- Transparency (20 pts) — public ownership, physical address, corporate entity, named leadership.
- Reputation (15 pts) — inverted complaint volume from Trustpilot + BBB + r/Peptides discussions.
- Compliance posture (15 pts) — visible compliance with research-use-only labeling norms; no dosing guides, therapeutic claims, or human-use imagery alongside sales.
This is editorial analysis, not vendor promotion. Vendors with active affiliate relationships are labeled. Vendors scored here without an affiliate relationship are covered journalistically; no outbound referral link is rendered.
Telehealth (FDA-approved GLP-1 dispensing)2 scored
Hims & Hers
No affiliate relationshipPublicly traded, FDA-approved branded product dispensing, but recent FDA scrutiny on marketing claims keeps this below A-range.
What works / where it falls short
Strengths
- • Dispenses FDA-approved branded Wegovy and Zepbound (not compounded)
- • NYSE-listed (HIMS), public financial disclosure and corporate transparency
- • Clear ownership, physical address, licensed pharmacy partners disclosed
Concerns
- • FDA has raised concerns about weight-loss marketing practices in 2024-2025
- • Some patient-complaint volume on Trustpilot around clinician-continuity and refund handling
Evidence
Ro
No affiliate relationshipWell-established telehealth platform now dispensing FDA-approved branded GLP-1s after compounding wind-down.
What works / where it falls short
Strengths
- • Dispenses branded Wegovy and Zepbound after 2025 compounding end
- • Strong clinical-intake workflow, documented medical-history collection
- • Publicly-held corporate entity with disclosed leadership
Concerns
- • Previously operated large compounded-semaglutide program; migration transparency mixed
- • Pricing ambiguity around ongoing subscription vs single-order charges
Research peptide vendors8 scored
Amino Club
No affiliate relationshipAmong the higher-transparency research-peptide vendors; still operates in the regulatory gray area of RUO-labeled sales.
What works / where it falls short
Strengths
- • Publishes batch-level Certificates of Analysis from independent labs
- • Clear affiliate program with defined commission structure (20% + 10% recurring)
- • No active FDA warning letters as of April 2026
Concerns
- • Markets peptides for human-adjacent use cases despite RUO disclaimers — FDA's 2024 warning-letter pattern suggests this is enforcement-adjacent
- • Ownership/corporate structure not as transparent as larger telehealth operators
Apollo Peptide Sciences
No affiliate relationshipActive affiliate program with lifetime rebills; standard research-peptide RUO posture with moderate transparency.
What works / where it falls short
Strengths
- • Batch COAs available on request
- • Established affiliate program via Refersion
- • Broad catalog including newer Phase 3 compounds
Concerns
- • Ownership structure not publicly disclosed
- • Marketing language adjacent to human-use cases
Limitless Life Nootropics
No affiliate relationshipFrequently-recommended by affiliate-heavy peptide review sites; credible concerns around paid-review coordination that the score reflects.
What works / where it falls short
Strengths
- • Broad catalog and competitive pricing
- • Published COAs for many products
Concerns
- • Paid-review allegations documented on Trustpilot + Reddit r/Peptides
- • Cross-referenced favorable coverage on peptides.org — which discloses an affiliate relationship with Limitless, raising conflict-of-interest questions
- • Corporate transparency limited
Pure Rawz
No affiliate relationshipLarge-catalog research vendor with mixed crowd-sourced reputation signals.
What works / where it falls short
Strengths
- • Large peptide catalog and SARMs inventory
- • Some published COAs
Concerns
- • Multiple Reddit r/Peptides threads raising crypto-payment and chargeback-handling concerns
- • Trustpilot complaint volume elevated relative to category
- • Marketing language around research use inconsistently applied
SwissChems
Affiliate declinedDecember 2024 FDA warning letter recipient. We editorially do not recommend.
Summit Research Peptides
Affiliate declinedRecipient of December 2024 FDA warning letter for selling semaglutide/tirzepatide/retatrutide as unapproved drugs. We editorially do not recommend.
Prime Peptides
Affiliate declinedDecember 2024 FDA warning letter recipient. We editorially do not recommend.
Peptide Sciences
No longer activeReportedly shut down under FDA pressure per 2026 industry reporting. No active operations; historical reputation was mixed.